跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RC-1
首页
药物
RC-1
RC-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
7-substituted 3-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
申请人: VETOQUINOL SA
优先权: 2009
CN
US
3 件公开
PROTEASE-RESISTANT COMPOUNDS USEFUL AS SHUTTLES THROUGH THE BLOOD-BRAIN BARRIER AND SHUTTLE-CARGO CONSTRUCTS
申请人: UNIV BARCELONA
优先权: 2012
US
Triazine compounds
申请人: ONO M
优先权: 2001
US
Pyrimidine compounds
申请人: SYNTA PHARMACEUTICALS CORP
优先权: 2001
US
4 件公开
Composition and light emitting device using the same
申请人: SUMITOMO CHEMICAL CO
优先权: 2017
CN
US
2 件公开
PHARMACEUTICAL COMPOSITION FOR TOPICAL USE THAT IS IN THE FORM OF A DISPERSED PHASE BASED ON AT LEAST ONE SHORT DIOL IN A CONTINUOUS FATTY PHASE AND COMPRISING AT LEAST ONE ANTI-INFLAMMATORY SUBSTANCE
申请人: SOC DEXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC
优先权: 2019
WO
Substituted pyrazines as DGAT-1 inhibitors
申请人: BIRCH ALAN MARTIN
优先权: 2010
CN
US
3 件公开
Prodrugs of non-steroidal anti-inflammatory and carboxylic acid containing compound
申请人: SPECIALIZED PHARMACEUTICAL RES
优先权: 2000
EP
US
3 件公开
药物
反馈